ALBERT DAVID
Back to Cashflow Statement
|
ALBERT DAVID Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-28 Cr | ₹46 Cr | ₹11 Cr | ₹40 Cr | ₹37 Cr |
What is the latest Cash Flow from Operating Activities ratio of ALBERT DAVID ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-28 Cr |
| Mar2024 | ₹46 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹40 Cr |
| Mar2021 | ₹37 Cr |
How is Cash Flow from Operating Activities of ALBERT DAVID Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-28 Cr | Negative | |
| Mar2024 | ₹46 Cr | 332.73 | |
| Mar2023 | ₹11 Cr | -73.98 | |
| Mar2022 | ₹40 Cr | 10.38 | |
| Mar2021 | ₹37 Cr | - | |
Compare Cash Flow from Operating Activities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹429.8 Cr | 1.2% | 9.5% | -33.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,717.0 Cr | 0.6% | 7% | 1.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,830.0 Cr | 1.6% | 4.6% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,479.0 Cr | 3.1% | 5.9% | 39% | Stock Analytics | |
| CIPLA | ₹108,978.0 Cr | 1.5% | -2.1% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,905.0 Cr | 0.5% | 9.8% | 5.7% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | 1.2% |
9.5% |
-33.4% |
| SENSEX | -0.6% |
0.6% |
9.8% |
You may also like the below Video Courses